1184
We conclude that low-dose HU therapy in patients with thalassemia intermedia may increase total Hb levels sufficiently to eliminate the need for transfusions.
 in patients with thalassemia intermedia: Subject; increase total Hb levels: Effect; low-dose HU therapy: Treatment; thalassemia intermedia: Treatment.Disorder; HU: Treatment.Drug; low-dose: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 in patients with thalassemia intermedia: Subject; increase total Hb levels: Effect; low-dose HU therapy: Treatment; thalassemia intermedia: Treatment.Disorder; HU: Treatment.Drug; low-dose: Treatment.Dosage